 | Led a multi-organizational business development initiative to support technology and market development of a single-use (disposable) endoscope for a supplier of minimally invasive interventional tools. |
| Following a technology assessment, identified specific products and associated marketing partners for a start-up firm intending to develop a unique method of drug delivery of large- and small-molecule compounds via oral administration, an approach so far deemed infeasible. |
| For a leading surgical products company, assessed the clinical applicability of a new implantable device for treatment of congestive heart failure, a technology being offered by a prospective partner. |
| For a potential marketing partner, evaluated the competitive positioning and prospective customer acceptability of a new pump for spinal drug delivery being developed by a medical-products design firm. |
| Provided guidance on commercial collaborations generally, and on negotiations with a potential distributor/collaborator in particular, to the CEO of a firm developing innovative nucleic acid sequencing technology. |
| For an Asian producer of plastic products, identified potential biomedical applications and corresponding customers for a new polymeric formulation offering superior protein-non-adsorption and solvent-resistant properties. |
| For a development-stage firm in the Middle East, explored potential clinical applications and prospective marketing partners for a small CCD-based camera designed as a videoendoscope component. |
| For a producer of point-of-care coagulation diagnostics, explored partnering mechanisms for increasing shareholder value. |
| For the inventor of a new anticoagulant drug, developed clinical and economic data to support our client in licensing negotiations with its partner, a major biopharmaceutical firm. |
| For a development-stage firm, assessed the economics of a variety of medical applications in order to realize the maximum commercial value from a broadly applicable invention for infection control. |
| For an investment firm seeking buyout targets, explored the potential acquisition of a manufacturer of analytical instrumentation for food, dairy and clinical laboratories, then solicited divestiture interest among existing shareholders. |
| For a large industrial materials firm, identified commercial bioprocessing and biomedical opportunities for the client's proprietary magnetic particle technology. |
| Provided divestiture support and brokerage services to the owner of a business offering pulmonary function testing equipment to the U.S. hospital market. |
©1998-2008 Trilogy Associates. All rights reserved.
Return to Home Page.